Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
11
Frequently Asked Questions
What is Market Cap of Oxurion NV?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Oxurion NV market cap is $433.72M.
What is the 52-week high for Oxurion NV?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oxurion NV 52 week high is $0.17 as of June 10, 2026.
What is the 52-week low for Oxurion NV?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oxurion NV 52 week low is $0.17 as of June 10, 2026.
What is Oxurion NV stock price today?
Oxurion NV stock price today is $0.17.
What was Oxurion NV stock price yesterday?
Oxurion NV stock price yesterday was $0.293.
What is the PE ratio of Oxurion NV?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Oxurion NV's P/E ratio is -0.42.
What is the Price-to-Book ratio of Oxurion NV?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Oxurion NV P/B ratio is -14.2857.
What is the 50-day moving average of Oxurion NV?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Oxurion NV 50-day moving average is $0.17.
